Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007751451> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2007751451 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCMolecular targeted agents are being a mainstay in non-small cell lung cancer. Dramatic responses to the epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitor (TKI) are observed in advanced non-small cell lung cancer (NSCLC), especially with EGFR mutation. Different from cytotoxic agents, it remains unclear whether EGFR-TKI exerts its anti-tumor effect dose-dependently. Gefitinib could not show survival benefit in previously treated unselected patients with NSCLC in a randomized phase III trial, whereas erlotinib did. The difference is considered resulting from the fact that erlotinib was dosed at its maximum-tolerated dose (MTD), while gefitinib was dosed at about one third of its MTD. To investigate the dose-dependency of gefitinib in the cells harboring mutated EGFR, we compared two doses of gefitinib (15 or 50 mg/kg) using PC-9 (adenocarcinoma of lung) xenografts. Both doses of gefitinib reduced tumors. However, the tumors regrew in the low-dose group after several weeks of treatment, whereas did not in the high dose group. This result indicates that gefitinib might have the dose-dependency in the tumors harboring mutated EGFR. We resected tumors at 10 weeks after gefitinib treatment. The removed tumors did not acquired T790M mutation and MET amplification. Interestingly, the cells (PC-9/RX) that were derived from the xenograft tumors treated with low-dose gefitinib remained the sensitivity to gefitinib. Thus, we investigated hepatocyte growth factor (HGF) as the environmental factor. Tumor tissues treated with gefitinib were positively stained with anti-mouse HGF. Mouse HGF mRNA and protein expression in the tumor tissues treated with gefitinib were significantly high when compared to those treated with vehicle alone, and similar results were obtained by ELISA. We confirmed that mouse HGF induced resistance to gefitinib in an ex vivo experiment. To elucidate the role of HGF in vivo, PC-9 xenografts were treated with gefitinib in combination with rabbit anti-HGF antibody. The combination of gefitinib with anti-HGF antibody inhibited tumor growth partially compared with the low-dose gefitinib alone. Taken together, HGF might induce resistance to low-dose of gefitinib treatment in an in vivo xenograft model before the tumor cells themselves acquired the resistant genetic changes.In conclusion, higher-dose of gefitinib might prevent resistance to gefitinib related to HGF and produce longer response duration.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 621." @default.
- W2007751451 created "2016-06-24" @default.
- W2007751451 creator A5001897650 @default.
- W2007751451 creator A5002407044 @default.
- W2007751451 creator A5007888883 @default.
- W2007751451 creator A5022919508 @default.
- W2007751451 creator A5035360618 @default.
- W2007751451 creator A5045098159 @default.
- W2007751451 creator A5050389295 @default.
- W2007751451 creator A5056975051 @default.
- W2007751451 creator A5065924920 @default.
- W2007751451 creator A5066700160 @default.
- W2007751451 creator A5070545496 @default.
- W2007751451 date "2010-04-15" @default.
- W2007751451 modified "2023-09-25" @default.
- W2007751451 title "Abstract 621: High-dose gefitinib overcomes the resistance to gefitinib related to hepatocyte growth factor" @default.
- W2007751451 doi "https://doi.org/10.1158/1538-7445.am10-621" @default.
- W2007751451 hasPublicationYear "2010" @default.
- W2007751451 type Work @default.
- W2007751451 sameAs 2007751451 @default.
- W2007751451 citedByCount "0" @default.
- W2007751451 crossrefType "proceedings-article" @default.
- W2007751451 hasAuthorship W2007751451A5001897650 @default.
- W2007751451 hasAuthorship W2007751451A5002407044 @default.
- W2007751451 hasAuthorship W2007751451A5007888883 @default.
- W2007751451 hasAuthorship W2007751451A5022919508 @default.
- W2007751451 hasAuthorship W2007751451A5035360618 @default.
- W2007751451 hasAuthorship W2007751451A5045098159 @default.
- W2007751451 hasAuthorship W2007751451A5050389295 @default.
- W2007751451 hasAuthorship W2007751451A5056975051 @default.
- W2007751451 hasAuthorship W2007751451A5065924920 @default.
- W2007751451 hasAuthorship W2007751451A5066700160 @default.
- W2007751451 hasAuthorship W2007751451A5070545496 @default.
- W2007751451 hasConcept C121608353 @default.
- W2007751451 hasConcept C126322002 @default.
- W2007751451 hasConcept C143998085 @default.
- W2007751451 hasConcept C170493617 @default.
- W2007751451 hasConcept C2776256026 @default.
- W2007751451 hasConcept C2776362946 @default.
- W2007751451 hasConcept C2777930144 @default.
- W2007751451 hasConcept C2778087573 @default.
- W2007751451 hasConcept C2778820342 @default.
- W2007751451 hasConcept C2779438470 @default.
- W2007751451 hasConcept C2780580887 @default.
- W2007751451 hasConcept C502942594 @default.
- W2007751451 hasConcept C71924100 @default.
- W2007751451 hasConcept C98274493 @default.
- W2007751451 hasConceptScore W2007751451C121608353 @default.
- W2007751451 hasConceptScore W2007751451C126322002 @default.
- W2007751451 hasConceptScore W2007751451C143998085 @default.
- W2007751451 hasConceptScore W2007751451C170493617 @default.
- W2007751451 hasConceptScore W2007751451C2776256026 @default.
- W2007751451 hasConceptScore W2007751451C2776362946 @default.
- W2007751451 hasConceptScore W2007751451C2777930144 @default.
- W2007751451 hasConceptScore W2007751451C2778087573 @default.
- W2007751451 hasConceptScore W2007751451C2778820342 @default.
- W2007751451 hasConceptScore W2007751451C2779438470 @default.
- W2007751451 hasConceptScore W2007751451C2780580887 @default.
- W2007751451 hasConceptScore W2007751451C502942594 @default.
- W2007751451 hasConceptScore W2007751451C71924100 @default.
- W2007751451 hasConceptScore W2007751451C98274493 @default.
- W2007751451 hasLocation W20077514511 @default.
- W2007751451 hasOpenAccess W2007751451 @default.
- W2007751451 hasPrimaryLocation W20077514511 @default.
- W2007751451 hasRelatedWork W1504213470 @default.
- W2007751451 hasRelatedWork W1987321907 @default.
- W2007751451 hasRelatedWork W2016986129 @default.
- W2007751451 hasRelatedWork W2018708014 @default.
- W2007751451 hasRelatedWork W2035711564 @default.
- W2007751451 hasRelatedWork W2048662229 @default.
- W2007751451 hasRelatedWork W2080080809 @default.
- W2007751451 hasRelatedWork W2081057157 @default.
- W2007751451 hasRelatedWork W2109866699 @default.
- W2007751451 hasRelatedWork W2305652235 @default.
- W2007751451 hasRelatedWork W2317096894 @default.
- W2007751451 hasRelatedWork W2606308058 @default.
- W2007751451 hasRelatedWork W2728483795 @default.
- W2007751451 hasRelatedWork W2916385328 @default.
- W2007751451 hasRelatedWork W2936688313 @default.
- W2007751451 hasRelatedWork W2968343719 @default.
- W2007751451 hasRelatedWork W2991599144 @default.
- W2007751451 hasRelatedWork W3018250288 @default.
- W2007751451 hasRelatedWork W3159404526 @default.
- W2007751451 hasRelatedWork W3200699844 @default.
- W2007751451 isParatext "false" @default.
- W2007751451 isRetracted "false" @default.
- W2007751451 magId "2007751451" @default.
- W2007751451 workType "article" @default.